These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22172803)

  • 1. Detection of IDH1 R132H mutation in acute myeloid leukemia by mutation-specific immunohistochemistry.
    Byers R; Hornick JL; Tholouli E; Kutok J; Rodig SJ
    Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):37-40. PubMed ID: 22172803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of IDH1 p.R132H Mutant Clones Using Mutation-specific Antibody in Myeloid Neoplasms.
    Kurt H; Bueso-Ramos CE; Khoury JD; Routbort MJ; Kanagal-Shamanna R; Patel UV; Jorgensen JL; Wang SA; Ravandi F; DiNardo C; Luthra R; Medeiros LJ; Patel KP
    Am J Surg Pathol; 2018 May; 42(5):569-577. PubMed ID: 29635257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of immunohistochemistry, DNA sequencing and allele-specific PCR for the detection of IDH1 mutations in gliomas.
    Loussouarn D; Le Loupp AG; Frenel JS; Leclair F; Von Deimling A; Aumont M; Martin S; Campone M; Denis MG
    Int J Oncol; 2012 Jun; 40(6):2058-62. PubMed ID: 22447191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia.
    Boutzen H; Saland E; Larrue C; de Toni F; Gales L; Castelli FA; Cathebas M; Zaghdoudi S; Stuani L; Kaoma T; Riscal R; Yang G; Hirsch P; David M; De Mas-Mansat V; Delabesse E; Vallar L; Delhommeau F; Jouanin I; Ouerfelli O; Le Cam L; Linares LK; Junot C; Portais JC; Vergez F; Récher C; Sarry JE
    J Exp Med; 2016 Apr; 213(4):483-97. PubMed ID: 26951332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of isocitrate dehydrogenase 1 gene mutation in 205 AML patients and its clinical significance].
    Shang Z; Wang D; Xiao M; Geng Z; Wang HX; Wang J; Xu YL; Li TJ; Zhou JF; Li CR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1307-11. PubMed ID: 23257422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing.
    Takano S; Tian W; Matsuda M; Yamamoto T; Ishikawa E; Kaneko MK; Yamazaki K; Kato Y; Matsumura A
    Brain Tumor Pathol; 2011 Apr; 28(2):115-23. PubMed ID: 21344322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of IDH1-R132H correlates with poor survival in gastrointestinal cancer.
    Li J; Huang J; Huang F; Jin Q; Zhu H; Wang X; Chen M
    Oncotarget; 2016 Nov; 7(45):73638-73650. PubMed ID: 27655638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis.
    Lin J; Qian J; Yao DM; Li Y; Yang J; Chen Q; Chai HY; Xiao GF; Xu WR
    Clin Biochem; 2011 Jul; 44(10-11):779-83. PubMed ID: 21539821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
    Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens.
    Preusser M; Wöhrer A; Stary S; Höftberger R; Streubel B; Hainfellner JA
    J Neuropathol Exp Neurol; 2011 Aug; 70(8):715-23. PubMed ID: 21760534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation syndrome during ivosidenib treatment with immunohistochemistry showing isocitrate dehydrogenase R132H mutation.
    Tabata MM; Chase M; Kwong BY; Novoa RA; Fernandez-Pol S
    J Cutan Pathol; 2020 Nov; 47(11):1042-1045. PubMed ID: 32588467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia.
    Koszarska M; Bors A; Feczko A; Meggyesi N; Batai A; Csomor J; Adam E; Kozma A; Orban TI; Lovas N; Sipos A; Karaszi E; Dolgos J; Fekete S; Reichardt J; Lehoczky E; Masszi T; Tordai A; Andrikovics H
    Leuk Lymphoma; 2013 May; 54(5):1028-35. PubMed ID: 23039322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-sensitive HMab-2 specifically detects IDH1-R132H, the most common IDH mutation in gliomas.
    Fujii Y; Ogasawara S; Oki H; Liu X; Kaneko MK; Takano S; Kato Y
    Biochem Biophys Res Commun; 2015 Oct; 466(4):733-9. PubMed ID: 26381180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies.
    Ikota H; Nobusawa S; Arai H; Kato Y; Ishizawa K; Hirose T; Yokoo H
    Brain Tumor Pathol; 2015 Oct; 32(4):237-44. PubMed ID: 26006098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients.
    Elsayed GM; Nassar HR; Zaher A; Elnoshokaty EH; Moneer MM
    J Egypt Natl Canc Inst; 2014 Mar; 26(1):43-9. PubMed ID: 24565682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
    Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
    Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant HIF1- α and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations.
    Ali T; Usman R; Shah SA; Parvez A; Anwar S; Muneer Z; Saeed M
    Cancer Control; 2024; 31():10732748241271714. PubMed ID: 39110525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations.
    Sellner L; Capper D; Meyer J; Langhans CD; Hartog CM; Pfeifer H; Serve H; Ho AD; Okun JG; Krämer A; Von Deimling A
    Eur J Haematol; 2010 Nov; 85(5):457-9. PubMed ID: 20659156
    [No Abstract]   [Full Text] [Related]  

  • 19. A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas.
    Casar-Borota O; Øystese KA; Sundström M; Melchior L; Popovic V
    Pituitary; 2016 Aug; 19(4):407-14. PubMed ID: 27097804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML).
    Steinhäuser S; Silva P; Lenk L; Beder T; Hartmann A; Hänzelmann S; Fransecky L; Neumann M; Bastian L; Lipinski S; Richter K; Bultmann M; Hübner E; Xia S; Röllig C; Vogiatzi F; Schewe DM; Yumiceba V; Schultz K; Spielmann M; Baldus CD
    Leukemia; 2023 Jan; 37(1):134-142. PubMed ID: 36411356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.